Boothbay Fund Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-14,568
| Closed | -$44K | – | 1591 |
|
2025
Q1 | $44K | Hold |
14,568
| – | – | ﹤0.01% | 1120 |
|
2024
Q4 | $52.7K | Buy |
+14,568
| New | +$52.7K | ﹤0.01% | 1187 |
|
2023
Q4 | – | Sell |
-36,000
| Closed | -$56.9K | – | 1862 |
|
2023
Q3 | $56.9K | Hold |
36,000
| – | – | ﹤0.01% | 1421 |
|
2023
Q2 | $77.8K | Sell |
36,000
-44,000
| -55% | -$95K | ﹤0.01% | 1416 |
|
2023
Q1 | $168K | Buy |
+80,000
| New | +$168K | ﹤0.01% | 1553 |
|
2021
Q4 | – | Sell |
-56,329
| Closed | -$511K | – | 2056 |
|
2021
Q3 | $511K | Buy |
56,329
+23,899
| +74% | +$217K | 0.01% | 882 |
|
2021
Q2 | $158K | Hold |
32,430
| – | – | 0.01% | 1427 |
|
2021
Q1 | $144K | Sell |
32,430
-9,250
| -22% | -$41.1K | 0.01% | 1197 |
|
2020
Q4 | $162K | Buy |
+41,680
| New | +$162K | 0.01% | 962 |
|
2019
Q2 | – | Sell |
-6,748
| Closed | -$52K | – | 829 |
|
2019
Q1 | $52K | Hold |
6,748
| – | – | 0.01% | 600 |
|
2018
Q4 | $47K | Hold |
6,748
| – | – | 0.01% | 512 |
|
2018
Q3 | $77K | Sell |
6,748
-737
| -10% | -$8.41K | 0.01% | 609 |
|
2018
Q2 | $95K | Buy |
+7,485
| New | +$95K | 0.01% | 560 |
|